Overview
Nishitha Reddy is a Hematologist Oncology specialist and an Oncologist in Nashville, Tennessee. Dr. Reddy is rated as an Advanced provider by MediFind in the treatment of T-Cell Lymphoma. Her top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Reddy is currently accepting new patients.
Her clinical research consists of co-authoring 109 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 8 articles in the study of T-Cell Lymphoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3601 The Vanderbilt Clinic, Nashville, TN 37232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Tennessee Oncology PLLC
Ian Flinn is a Hematologist Oncology specialist and a Hematologist in Tullahoma, Tennessee. Dr. Flinn is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. His top areas of expertise are Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Flinn is currently accepting new patients.
John Greer is a Hematologist in Nashville, Tennessee. Dr. Greer is rated as an Advanced provider by MediFind in the treatment of T-Cell Lymphoma. His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Follicular Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
Sarah Cannon Research Institute
Dr. Patel joined SCRI in 2024, as director of lymphoma research, and oversees SCRI’s comprehensive lymphoma clinical trial portfolio. Previously, he served as the Director of Hematologic Malignancies and Cell Therapy at the Swedish Cancer Institute in Seattle, Washington, where he led development of the program’s clinical standards for lymphoma care, assisted in the expansion of cell therapy services, and helped shape lymphoma research efforts. Dr. Patel was also a member of the Paul G. Allen Research Center at Seattle Cancer Institute, serving as a co-founding member of the Center for Immuno-oncology, where he collaborated on translational research related to immunotherapy in hematologic diseases.Dr. Patel has been published in various medical journals, including New England Journal of Medicine, Blood, and Journal of Clinical Oncology. He is also a member of the ASCO Cancer Communications Committee, the CIBMTR Lymphoma Working Committee, and the National Planning Committee for the Lymphoma Research Foundation Lymphoma Rounds. His clinical and research focus is in lymphomas, CLL, and cellular therapy. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of T-Cell Lymphoma. His top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Follicular LymphomaDr. Reddy isElite. Learn about Follicular Lymphoma.
- Non-Hodgkin LymphomaDr. Reddy isElite. Learn about Non-Hodgkin Lymphoma.
- Distinguished
- B-Cell LymphomaDr. Reddy isDistinguished. Learn about B-Cell Lymphoma.
- Burkitt LymphomaDr. Reddy isDistinguished. Learn about Burkitt Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Reddy isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Reddy isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Hodgkin LymphomaDr. Reddy isDistinguished. Learn about Hodgkin Lymphoma.
- Large-Cell Immunoblastic LymphomaDr. Reddy isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Reddy isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Anaplastic Large Cell LymphomaDr. Reddy isAdvanced. Learn about Anaplastic Large Cell Lymphoma.
- Autoimmune Hemolytic AnemiaDr. Reddy isAdvanced. Learn about Autoimmune Hemolytic Anemia.
- Bone Marrow AspirationDr. Reddy isAdvanced. Learn about Bone Marrow Aspiration.
- Childhood Acute Myeloid Leukemia
- Experienced
- Acquired HemophiliaDr. Reddy isExperienced. Learn about Acquired Hemophilia.
- Acute Eosinophilic PneumoniaDr. Reddy isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Lymphoblastic Leukemia (ALL)Dr. Reddy isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myelomonocytic LeukemiaDr. Reddy isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Reddy isExperienced. Learn about Acute Promyelocytic Leukemia.